40 results about "Hygromycin B" patented technology

The invention relates to a double resistance CRISPR/Cas9 carrier and application. The invention provides the double resistance carrier having both hygromycin B resistance and Basta resistance at the same time; the double resistance carrier is obtained by inserting sequences and fragments derived from multiple different carriers into a sequence of a carrier pFGC5941 by enzyme-cutting and linking up, and constructing. Hygromycin B is used for screening in a conversion process, and Basta is used for screening offspring transgenic plants not containing an external source T-DNA sequence in offspring plants. Two resistances, i.e., the hygromycin B and the Basta are used to respectively serve as screening marks of the transgenic plants for the first time, a feasible manner is provided for screening transgenic offspring not containing the external source T-DNA sequence, determining the existence of external source T-DNA by a complex molecular biology detection experiment is avoided, and the offspring transgenic plants not containing the external source T-DNA sequence can be obtained by directly screening the Basta resistance and performing phenotype combination.

The invention discloses a method for breeding a high-producing strain of cellulase by gene knockout, and belongs to the field of enzyme engineering. The method for breeding the high-producing strain of cellulase by gene knockout comprises the step of knocking out an amylase gene of the cellulase producing strain. A high-producing strain of cellulase is aspergillus niger without the amylase gene. An amylase gene knockout plasmid is obtained by connecting the front half part of the recombinant segment amylase gene-hygromycin B-an expression unit of a resistant gene- the rear half part of the amylase gene to a pCAMBIA1300 plasmid. Then, the plasmid is converted into agrobacterium, and the amylase gene is knocked out by agrobacterium-mediated conversion of the aspergillus niger. By using the gene knockout technology, the amylase gene of the aspergillus niger is knocked out. After the amylase gene is knocked out, the cell load is reduced, thereby facilitating production of a lot of cellulase. The cellulase activity of the high-producing strain of cellulase obtained can reach 21U/g.

The invention discloses a watermelon oxysporum pathogenic FonAGL3 gene as well as a deleted DNA fragment, a deletion mutant and application thereof, and aims to solve the technical problem of biological prevention and treatment on watermelon oxysporum. A pathogenic gene FonAGL3 derived from watermelon fusarium oxysporum is analyzed and screened by inserting watermelon oxysporum T-DNA into a mutant library, by utilizing the homologous gene replacement principle, DNA fragments of the target gene FonAGL3 are replaced by gene DNA fragments of a resistance gene hygromycin B (HPH), a FonAGL3 gene deletion mutant is obtained by establishing a gene deletion carrier and implementing genetic transformation of a wild strain FON-11-06, and the FonAGL3 mutant bacterium has a good wilt prevention and treatment effect and is environmental-friendly and low in prevention and treatment cost.

The invention relates to a high-throughput screening system for breeding high-nucleic-acid yeast. The high-throughput screening system comprises reporter plasmid Yep-Hyg B-yeGFP and a host cell containing the Yep-Hyg B-yeGFP, wherein the reporter plasmid Yep-Hyg B-yeGFP is annular and sequentially comprises a YEplac195 plasmid skeleton, a yeast enhanced green fluorescent protein gene yeGFP expression box and a hygromycin B resistance gene expression box from 3' to 5'; the original strain of the host cell is a saccharomyces cerevisiae industrial strain whose nucleic acid content is confirmed tobe higher than a normal value through screening. The invention further discloses application of the screening system in high-nucleic-acid yeast engineering bacterium breeding. The screening system has the advantages that the defect that traditional high-nucleic-acid yeast breeding cannot directly reflect RNA content can be overcome, the instability of the plasmid in the yeast can be utilized to easily eliminate the plasmid through continuous passage, and the system is significant to the application of the high-nucleic-acid yeast in food industry.

The invention discloses a method for agrobacterium-induced genetic transformation of Ustilaginoidea virens. The method comprises the following steps of carrying out pre-induction culture on agrobacterium containing a hygromycin B gene and a marker gene, mixing an Ustilaginoidea virens spore liquid and the pre-induced agrobacterium liquid according to a volume ratio of 1: 1 to obtain a mixed bacterium liquid, uniformly coating the mixed bacterium liquid on an acetosyringone-containing modified AIM solid medium flat plate of which the surface is coated with a filter paper, a PVDF film or a nitrocellulose film, carrying out co-culture in the dark at a temperature of 20-24 DEG C for 36-48h, shearing the co-cultured film into small slices, paving the small slices on a modified selective medium CM, and carrying out culture at a temperature of 26 DEG C for 4-5 days to obtain hygromycin B gene-containing Ustilaginoidea virens. The method shortens converter time by 4-5d and has a conversion rate of 91.3%. The transgenic Ustilaginoidea virens has stable offspring, a low gene loss rate and converter stability of 95%.

The invention discloses aureobasidium pullulan alb1 gene knockout mutant strain. According to the mutant strain, all or part of coding genes in alb1 gene in aureobasidium pullulan strain are knocked out and replaced by a hygromycin B resistance gene cassette. The hygromycin B resistance gene cassette comprises aureobasidium pullulan transcription elongation factor promoter PTEF and hygromycin B resistance gene HrgR; the sequence of the aureobasidium pullulan transcription elongation factor promoter PTEF is as shown in SEQ ID NO.2 in a sequence table; the sequence of the hygromycin B resistance gene HrgR is as shown in SEQ ID NO.3 in the sequence table. The mutant strain is used for the fermentation production of microbial polysaccharide, does not produce melanin, and can obviously the yield and quality of polysaccharide during the purification process.

The invention discloses a fusarium oxysporum f.sp.niveum RNAi component FonDCL1 gene deletion mutant and a construction method thereof. According to the fusarium oxysporum f.sp.niveum RNAi component FonDCL1 gene deletion mutant and the construction method thereof, according to a reported Dicer like 1 protein sequence, homologous alignment is conducted on a Fon genomic sequence to obtain a fusariumoxysporum f.sp.niveum FonDCL1 gene, by adopting a homologous gene substitution principle, by means of a Split-marker strategy, the target gene FonDCL1 is substituted for a hygromycin B (HPH) gene DNAfragment, and by constructing a homologous gene recombinant fragment, through genetic transformation of a wild strain Fon1, the FonDCL1 gene deletion mutant is obtained. The FonDCL1 mutant has the advantages that the virulence to watermelon seedlings is enhanced, and the FonDCL1 mutant is more sensitive to abiotic stress factors of monensin sodium salt, hydroxycarbamide, a fluorescent whitening agent CFW, Congo red (CR), hydrogen peroxide and the like, so that a research foundation is provided for functional assignment of small RNA generated in processes of self growth and development and watermelon infection of the Fon1.

The invention relates to an Flp-In-293 cell line for expressing a bovine gamma interferon. The cell line is named B1 and contains a gene for encoding the bovine gamma interferon. A method for constructing the cell line B1 comprises the following steps of: constructing preBoIFN-gamma fragments which are correctly sequenced into a recombinant plasmid pcDNA5/FRT-preBoIFN-gamma-FLAG, cotransfecting Flp-In-293 cells by using the recombinant plasmid pcDNA5/FRT-preBoIFN-gamma-FLAG and a recombinase expression vector pOG44 by a liposomal transfection method, screening positive clones by a dulbecco's modified eagle medium (DMEM) containing 120mu g/mL Hygromycin B, performing amplification culture, subcloning through limiting dilution analysis, and identifying to obtain a recombinant cell line. The bovine gamma interferon secreted by the cell line B1 has extremely high specific activity and stability.

The invention discloses a salvia miltiorrhiza bunge genetic transformation method which has the advantages of simplicity and convenience in operation, high repeatability and capability of rapidly and effectively acquiring genetically modified salvia miltiorrhiza bunge plants. At present, most salvia miltiorrhiza bunge plant genetic transformation systems adopt Kanamycin (abbreviated as Kan) for screening. However, inventors find that 99-3 salvia miltiorrhiza bunge leaves are sensitive to the Kanamycin in genetic transformation research for 99-3strain salvia miltiorrhiza bunge subjected to sequencing, leaf growth is easily stopped when the Kanamycin is used as a screening antibiotic, and experimental reproducibility is poor. When 30-60mg/L Hygromycin B (abbreviated as Hyg) is used for screening, positive genetically modified plants are obtained, and positive rate is quite high. In conclusion, the salvia miltiorrhiza bunge plant genetic transformation method taking the salvia miltiorrhiza bunge leaves as explants is efficient, reliable and simple and convenient to operate. The method is mediated by agrobacterium tumefaciens, plasmid carrying exogenous genes are transformed into the salvia miltiorrhiza bunge, and the positive genetically modified salvia miltiorrhiza bunge plants are obtained.

The invention belongs to the technical field of plant genetic engineering in the plant biotechnology, and particularly relates to an agrobacterium rhizogenes mediated genetically modified Erigeron breviscapus hairy root transformation method. Pre-cultivated Erigeron breviscapus aseptic seedling blade explant is soaked in a C58C1 agrobacterium rhizogenes bacterial liquid carrying recombinant plasmid, hairy roots are cultivated on a selection medium containing hygromycin B (Hyb) for selection after infection, co-culture and bacteria removing, and a liquid medium is used for cultivating after a PCR amplification method is used for further identifying genetically modified roots carrying target genes. With the adoption of the technical scheme, the target genes can be guided into Erigeron breviscapus, and compared with genetic transformation of chemical methods of polyethylene glycol and the like, protoplast separation and cultivation segments are reduced; compared with genetic transformation of physical methods of a gene gun and the like, expensive instrument and equipment are not required, and the operation technique is simple.

The invention relates to a culture medium for acquiring and isolating conidia of isaria fumosorosea in greenhouses and a method for preparing the culture medium, and belongs to the field of technologies for isolating and culturing microorganisms. The culture medium for acquiring and isolating the conidia of the isaria fumosorosea in the greenhouses comprises, by weight, 15-20% of potatoes, 1.5-2.0% of sucrose, 25-100 micro-g/ml of ampicillin, 25-100 micro-g/ml of hygromycin B, 1.0-3.0% of agar and the balance distilled water. A pH (potential of hydrogen) value of the culture medium is 7.0-10.0. The culture medium and the method have the advantages that the conidia of the isaria fumosorosea can be acquired and quickly isolated by the culture medium, the quantities of target bacterial colonies on flat plates can be detected, and accordingly diffusion conditions of the conidia of the isaria fumosorosea in control regions can be detected and quantitatively evaluated; the culture medium is high in isolation speed and detection efficiency, and scientific bases can be provided for formulating pest control strategies.

The invention discloses a cell strain capable of stably secreting and expressing IL-24 recombinant protein, and construction and application thereof, belonging to the technical field of gene engineering. The construction method of the cell strain comprises the following steps: subcloning CDS region sequence of IL-24 gene into pcDNA5/FRT plasmid of an Flp-In targeted integration system, transfecting into Flp-In-CHO cell together with plasmid pOG44, and screening the stable-expression cell strain by using antibiotic Hygromycin B; purifying the recombinant protein in the cultured supernatant of the cell strain by affinity chromatography; and finally, carrying out in-vivo and in-vitro activity experiments to prove that the recombinant protein has an action on inhibiting esophagus cancer cells and melanoma cells from proliferation and can induce the apoptosis of the esophagus cancer cells and melanoma cells, thereby developing an effective new drug for treating tumors.

The invention relates to a traceless gene editing method for trichoderma fungi. According to the method, the traceless knockout mutant of the trichoderma guizhouense ura3 gene is obtained through twotimes of homologous recombination events and in combination with the resistance screening strategy of hygromycin B and the lethal strategy of 5-FOA; based on the mutant, the knockout fragment containing the ura3 gene expression cassette is inserted at the position of the target gene through the homologous recombination method, and the mutant having the first-time homologous recombination is screened by utilizing the nutrition defect feature of the ura3 traceless mutant; after the second-time homologous recombination, the ura3 gene and the target gene are removed through recombination, at the time, inverse screening is carried out by utilizing the lethal feature of 5-FOA, and thus the traceless mutant with the target gene completely deleted is obtained. The system is optimized sufficiently,the homologous recombination ratio is 15% or above, the single-gene traceless operating period is shortened to be within 15 days, meanwhile, the traceless overexpression of the target gene can be realized, and no exogenous fragments are introduced during the process.

The invention discloses an antibiotic namely hygromycin B that is sensitive to crypthecodinium cohnii producing DHA and a method using hygromycin B as the resistance screening marker to transform the gene of crypthecodinium cohnii. The method comprises the following steps: (1) determining the action concentration of hygromycin B; (2) establishing a gene transformation system; (3) preparing an exogenous gene section; (4) converting crypthecodinium cohnii by the exogenous gene section. According to the method, an exogenous gene can be introduced into cells of crypthecodinium cohnii, and at the same time, hygromycin B is taken as the screening marker to obtain an engineering strain of crypthecodinium cohnii with an exogenous gene. An important technological base is provided for the genetic engineering of crypthecodinium cohnii.

The invention discloses a hybridoma cell strain ZXL-1 secreting a specific monoclonal antibody to HB (hygromycin B) and an application of the hybridoma cell strain ZXL-1 and belongs to the technical field of immunodetection. The hybridoma cell strain ZXL-1 secreting the specific monoclonal antibody to the HB has been collected in CGMCC (China general microbiogical culture collection center) of CCCCM (China committee for culture collection of microorganisms) with the collection number of CGMCC No. 13097. The anti-HB monoclonal antibody is obtained from the obtained hybridoma cell strain ZXL-1 specifically secreting the antibody to the HB after ascites preparation and purification. The antibody can be used for immunodetection of HB residues in animal-derived food and meet the market requirement for quick HB immunodetection products at present.

The invention discloses an RNAi component FonAgol gene deletion mutant of fusarium oxyspirum f.sp.niveum and a construction method of the RNAi component FonAgol gene deletion mutant. The RNAi component FonAgol gene deletion mutant and the construction method thereof are characterized in that a reported Argonaute protein sequence is homologously compared with a Fon gemonic sequence to obtain a FonAgol gene of the fusarium oxyspirum f.sp.niveum; a target gene FonAgol is replaced with a DNA fragment of a hygromycin B (HPH) gene by adopting a homologous gene replacement principle and using a Split-marker strategy; a gene deletion mutant of the FonAgol is obtained by constructing a gene homologous recombination fragment and using genetic transformation of a wild strain Fon1. The FonAgol mutanthas the characteristics of higher sensitivity to pathogenicity weakening of watermelon seedlings, abiotic stress factors such as fluorescent brightener CFW, Congo red CR and hydroxycarbamide and the like, which provides a research foundation for growth and development of Fon1 and functional assignment of small RNA produced in the process of infection watermelons.

The invention relates to a high yielding cellulase engineering bacterium. The high yielding cellulase engineering bacterium is prepared through the following steps: composing a recombinant fragment by using the first half of amylase gene, a hygromycin B resistant gene expression unit and the latter half of the amylase gene, and carrying out enzyme digestion on the recombinant fragment by using a NcoI enzyme solution at 32.3-33.4DEG C; carrying out enzyme digestion on a pCAMIA1300 plasmid by using a NcoI enzyme; connecting the enzyme digested recombinant fragment with the enzyme digested plasmid through a DNA ligase to obtain an amylase gene knockout plasmid; converting Agrobacterium by using the amylase gene knockout plasmid; and carrying out mixing culture on the amylase gene knockout plasmid-containing Agrobacterium and Aspergillus niger, and carrying out hygromycin B resistance screengin to obtain the Aspergillus niger of the knockout amylase gene. The cellulase engineering bacterium provided by the invention substantially improves the output of cellulase, and is suitable for being used in industrial large-scale production.

The invention provides construction of a model of co-expression uptake of a carrier and a drug-metabolizing enzyme. The construction comprises the following steps: amplifying a human gene OAT1cDNA used as a template to obtain a human OAT1 gene segment, connecting the obtained human OAT1 gene segment to a carrier pcDNA3.1(+) to obtain a plasmid pcDNA3.1(+)/OAT1, transfecting MDCK (Madin Darby Canine Kidney) cells, and screening to obtain MDCK-hOAT1 cells in which the OAT1 is highly expressed; connecting a human CYP1A2 gene segment to a carrier pcDNA3.1(+)/Hygro(+) to obtain a plasmid pcDNA3.1/Hygro(+)/CYP1A2, transfecting the MDCK-hOAT1 cells, screening by using a hygromycin B to obtain cells of co-expression of OAT1 and CYP1A2, then carrying out mRNA verification on the cells and also carrying out functional verification by virtue of a classic substrate and an inhibitor. The cell model can be applied to cellular-level screening based on the medical toxic effects of OAT1 and CYP1A2, and therefore, prediction of the synergistic effect of the two proteins in a medicine disposition process is realized and a basis can be provided for clinical rational medications. The cell model is rational in design and high in repeatability.

The invention provides a method for exogenous gene genetic transformation of rhizopus nigericans by protoplast transformation technology, which comprises the following steps: treating cell walls of rhizopus nigericans by fungal cell wall degrading enzyme to obtain protoplast, purifying the protoplast, introducing rhizopus oryzae NADPH-cytochrome P450 reductase CYPOR (abbreviated as CPR gene) genes into rhizopus nigericans for the first time by using a protoplast transformation method with hygromycin B as a selective marker, so as to obtain the genetically engineered bacteria. The beneficial effects of the invention are that: the method can be used for molecular biology research of rhizopus nigericans, such as the molecular mechanism of the hydroxylation effect of the P450 enzyme system of the bacteria on steroids, and the like; the method can perform genetic engineering of rhizopus nigericans for genetic improvement breeding so as to increase the conversion rate of hydroxylation of steroid substrates by rhizopus nigericans.

The invention relates to the fields of microbial technologies and biological prevention and control, and particularly relates to an application of a trichoderma brevicompactum 0248 transformant with hygromycin B resistance in improvement of trichodermin yield. Through obtaining the trichoderma brevicompactum transformant containing a hygromycin B resistance gene, and adding hygromycin B to a liquid fermentation culture medium, the concentration of trichodermin in the fermentation liquid is improved. A reliable method is provided for improving the fermentation unit of trichodermin; and an application of the trichoderma brevicompactum transformant with hygromycin B resistance in improvement of the trichodermin yield is provided.

The invention relates to the technical field of gene engineering, particularly to a GluR1/GluR2 cell strain capable of stably expressing an AMPA receptor, and a construction method thereof. Accordingto the construction method disclosed by the invention, a cell strain capable of stably expressing an AMPA receptor GluR1/GluR2 is prepared. According to the scheme, retrovirus mediated gene expressionis adopted, hygromycin B is added for screening for two weeks, and the cell strain stably expressing the AMPA receptor GluR1/GluR2 is obtained; after the AMPA receptor GluR1/GluR2 stably transfectedcell strain is subjected to passage six times, the GluR1 and the GluR2 in the cell strain are still stably expressed, and the GluR1 and the GluR2 interact with each other; and the cell strain can provide basic research materials, experimental tools and carriers for analysis of AMPA receptor functions in diseases such as cerebral apoplexy and the like and probe development.